Background/Objectives: To assess safety during a diet based on low-fat foods enriched with nonesterified wood-derived plant sterols and mineral nutrients related to serum phytosterol, sex hormone and fat-soluble vitamin metabolism. Subjects/Methods: Seventy-one study participants (52 women, 19 men) with mild-to-moderate hypercholesterolemia completed the double-blind, placebo-controlled feeding trial lasting for 15 weeks. The subjects were randomly allocated to the sterol group receiving food items enriched with mineral nutrients as well as with a total of 1.25, 2.5 and 5.0 g per day of plant sterols during the first, second and third 5-week periods, respectively, or to the placebo group receiving similar food items without plant sterols. This outpatient clinical trial with free-living subjects was carried out at two hospital clinics. Results: Two significant findings were observed. Serum sitosterol concentrations increased from 2.84 to 5.35 mg l À1 (Po0.004 vs placebo) but those of serum total plant sterols did not because of compensatory changes in other phytosterols. The highest plant sterol levels did not exceed 0.6% of total serum sterols. Serum a-tocopherol concentrations decreased in the sterol group by 10% (Po0.0002), but the between-group difference disappeared after adjusting for the change in the carrier (LDL cholesterol). Conclusions: Fifteen-week consumption of natural nonesterified plant sterol-enriched food does not cause any serious adverse effects during such a period. However, serum a-tocopherol levels were somewhat reduced in the sterol group suggesting that long-term effects of plant sterols on serum fat-soluble vitamin concentrations should be further explored, especially in relation to very low-fat diets.
Introduction
Margarines containing plant stanol esters (Miettinen et al., 1995) or plant sterol esters (Weststrate and Meijer, 1998) have been shown to be useful in lowering serum cholesterol, an effect based on the ability of these substances to inhibit cholesterol absorption in the intestine (Tikkanen, 2005) . We have previously explored the possibility of lowering serum cholesterol using nonfat and low-fat food items enriched with up to 5 g per day of natural nonesterified plant sterols in a randomized, double-blind, placebo-controlled feeding trial lasting for 15 weeks (Tikkanen et al., 2001) . Seventy-eight subjects with serum cholesterol between 6 and 8 mmol l
À1
were randomly allocated to receive active (sterol) diet consisting of bread, meat products and jam enriched with 1.25-5.0 g per day of plant sterols and slightly elevated concentrations of mineral nutrients, or the corresponding food items without these enrichments. Serum cholesterol decreased by 8 and 3% in the sterol and placebo groups, respectively, and the corresponding reductions in LDL cholesterol were 13 and 5%. A large variety of safety parameters were measured and are now reported here.
Plant sterol and stanol-enriched common foods may become a widely used method in controlling high serum cholesterol levels. While the potential efficacy of these natural substances has been recognized by many experts and also by the National Cholesterol Education Program in the United States (Expert Panel, 2001 ), safety issues have received an increasing attention. Although cholesterollowering drugs have to be tested in large, controlled trials, foods supplemented with plant sterols and stanols or any other lipid-modifying food ingredients can be marketed without any evidence from trials testing for the efficacy or safety. Moreover, a concomitant intake of several such products (for example, margarine, yogurt, cheese) may increase the daily dose significantly. On this basis, we addressed possible safety concerns of nonesterified plant sterols in our previous study (Tikkanen et al., 2001 ) utilizing blood samples obtained during the study. We identified three potentially important areas. First, enrichment of foods with plant sterols might possibly result in enhanced intestinal absorption of these substances; in theory, this could lead to deleterious effects. This argument is based on the existence of rare inherited disorder sitosterolemia (phytosterolemia) characterized by enhanced intestinal absorption of plant sterols, elevated plasma plant sterol levels and early atherosclerosis (Salen et al., 1992) . Second, the inhibition of cholesterol absorption may be associated with a reduced intestinal absorption of other important hydrophobic substances such as fatsoluble vitamins. Third, some reports have speculated that b-sitosterol has some although weak estrogenic activity (Malini and Vanithakumari, 1993; Mellanen et al., 1996) , suggesting that plant sterol ingestion could influence the sex hormone balance. We set out to investigate these three areas of a potential concern by careful analysis of the serum plant sterol, fat-soluble vitamin and sex hormone concentrations in blood samples obtained from the participants of the plant sterol feeding study (Tikkanen et al., 2001 ).
Methods

Subjects
The study participants have been described previously in detail (Tikkanen et al., 2001) . In short, a total of 78 subjects with mild-to-moderate hypercholesterolemia (serum cholesterol 6-8 mmol l À1 ) were randomized into this trial. A total of 73 of the individuals randomized (36 in the sterol diet group and 37 in the control group) completed the trial, but two were excluded from statistical analysis because their medication changed during the trial. The participants (52 women and 19 men) were 27-74 years old, at baseline their mean serum total cholesterol levels (mean±s.d.) were 6.81±0.68 and 6.54 ± 0.61 mmol l
À1
, and they had a mean body mass index of 25.8 ± 3.4 and 26.8 ± 3.7 kg m À2 in the sterol diet and placebo (nonsterol diet) groups, respectively. People with severe diseases or taking drugs with serum lipidmodifying effects were excluded. All subjects received both written and oral information regarding the trial and gave a signed informed consent. The study protocol was approved by the Ethics Committee at the Department of Medicine, Helsinki University Central Hospital.
Study design
The trial was carried out using a double-blind design. The screening (run-in) period before the random allocation of the study participants into active treatment (sterol) and control (placebo) groups lasted for 4 weeks. At the first visit the participants completed a 3-day food diary, based on which a nutritionist decided whether a dietary stabilization period was required. If needed, the study participants received appropriate dietary advice during the stabilization period and it was recommended that they do not start a weight reduction action during the study. During the last 2 weeks of the run-in period all study participants received the control (placebo) food items.
After the run-in period, study participants were randomized into the sterol and placebo diet groups for the 15-week treatment period. Laboratory tests were carried out after each 5-week period. The study participants assigned to the sterol group received the food items enriched with mineral nutrients as well as with a total of 1.25, 2.5 and 5.0 g per day of plant sterols during the first, second and third 5-week periods, respectively. Those allocated to the placebo group received matching placebo food items.
Study food items and diet
The study food items containing a wood-derived sterol mixture and mineral nutrients have been described earlier (Tikkanen et al., 2001) . In summary, three types of plant sterol-enriched food items were consumed: bread, nonflavored yogurt with jam and meat products. In the active diet group each food type comprised one-third of the daily plant sterol dose (Table 1 ). In the placebo diet group identical commercial food items without sterol and mineral nutrient additions were used. The sterol powder used in the sterolfortified group consisted of approximately 79% sitosterol, 11% sitostanol, 7.5% campesterol and small amounts campestanol, cycloartenol and D-7-avenasterol.
All participants kept a 3-day (2 week days and 1 weekend day) food diary five times during the study, once during the baseline (home diet), once during the placebo run-in period and three times during dietary treatment period. Portion sizes were estimated using a validated (Pietinen et al., 1988) portion size picture booklet (Haapa et al., 1985) . The food diaries were checked by nutritionists. Nutrient intakes were computed using a program developed at the National Public Health Institute (Ovaskainen et al., 1996) .
Laboratory analyses
Blood samples were taken after a 12-h fast. Serum or plasma samples for plant sterol, fat-soluble vitamins and sex hormones were stored at -20 or -70 1C until analyzed. Cholesterol and triacylglycerol concentrations in total serum were determined by enzymatic colorimetric methods. HDL cholesterol was determined directly in serum (Sugiuchi et al., 1995) . The LDL cholesterol concentration was calculated using the Friedewald approximation (Friedewald et al., 1972) .
Serum plant sterol concentrations were analyzed four times during the trial using a gas chromatographic method (Phillips et al., 1999) . For the daily quality control, an in-house serum control sample was analyzed in each sample assay. Plant sterol contents of the control sample analyzed on 19 different days were as follows: 5.3 ± 0.7, 1.8 ± 0.2, 0.4 ± 0.2 and 0.4 ± 0.1 mg l À1 for campesterol, sitosterol, stigmasterol and D5-avenasterol, respectively. Serum plant sterol concentrations were analyzed in a subgroup of 20 randomly selected subjects (12 and 8 in the sterol and placebo groups, respectively).
Testosterone was determined with a direct coated tube radioimmunoassay (RIA) (Spectrial; Orion Diagnostica, Espoo, Finland) and estradiol with an RIA (Clinical Assays, DiaSorin Saluggia, Italy) after an in-house diethylether extraction. Sex hormone-binding globulin (SHBG), luteinizing hormone (LH), Follicle-stimulating hormone (FSH) and prolactin were determined with time-resolved immunofluorometric assays on an automatic immunoanalyzer (AutoDELFIA; Wallac, Finland). The assay protocols followed those outlined by the manufacturers except for the additional extraction for the estradiol assay. The detection limit for the testosterone assay is 100 pmol l À1 and that of estradiol 18 pmol l
À1
. ). Fat-soluble vitamins were analyzed at baseline and at the end of the treatment period. The vitamin assays (plasma retinol, a-tocopherol and b-carotene) were carried out using high-performance liquid chromatography (Porkkala-Sarataho et al., 1996) . Briefly, the analytes were extracted from plasma with hexane and ethanol and subjected to reversed phase column chromatography (LichroCART; Merck, Darmstadt, Germany) using a Beckman 118 pump (Beckman Instruments, San Ramon, CA, USA), a Beckman 507 autosampler and a Beckman System Gold Diode Array Detector 168.
Statistical analyses
The analyses were performed with SAS software (Statistical Analysis System, version 6.12; SAS Institute Inc., Cary, NC, USA). Normal distribution of variables was checked with the Shapiro-Wilks test (SAS Procedures Guide, 1990) . The results are expressed as means±s.d. or for variables not normally distributed as medians and ranges. All statistical analyses were performed according to intention to treat. Differences in changes before and after the trial periods were tested with t-tests between groups. The nonparametric Wilcoxon ranksum test was used for variables, which were not normally distributed. A P-value o0.05 for the differences between means of treatment groups was considered statistically significant.
Results
Plant sterols
Serum plant sterols were determined in a randomly chosen subgroup of study participants (12 and 8 subjects in the sterol and placebo groups, respectively; Table 2 ). The mean serum sitosterol concentration increased progressively in a dose-dependent way from the baseline level of 2.84-5.35 mg l À1 by 15 weeks in the sterol group (P ¼ 0.0042 vs placebo). The total plant sterol concentration also increased, although not significantly, due to slight compensatory decreases in campesterol and avenasterol concentrations, and thus total plant sterol levels did not differ between treatment groups after 15 weeks. The highest individual total plant sterol level measured at the end of the treatment period was 14.4 mg l À1 among men and 15.3 mg l À1 among women, which amounted to approximately 0.6% of the mean serum cholesterol (2462 and 2410 mg l À1 in men and women, respectively).
Sex hormones
The results of baseline and post-treatment values of serum sex hormones are shown in Table 3 for men and Table 4 for women. The results of pre-and postmenopausal women were analyzed separately. There were no statistically significant differences in serum sex hormone levels between the treatment groups during the trial in either gender. The mean progesterone concentrations in premenopausal women in the sterol group at baseline and after 15 weeks were markedly higher than in the placebo group, possibly due to the great cyclic variation of progesterone levels.
Fat-soluble vitamins
The levels of retinol and b-carotene did not change significantly during the trial (Table 5 ). The serum concentration of a-tocopherol decreased significantly in the active treatment group compared with placebo by approximately 10% (Po0.0002), but after adjusting for the change in serum LDL cholesterol this difference was no longer present (P ¼ 0.79). 
Diet during the trial
The composition of the diet at baseline (home diet), and at the end of the treatment period was estimated by 3-day food records. At baseline, there were no significant differences in any calculated dietary intakes between the sterol and placebo groups, nor did the groups differ significantly in changes of the intakes of energy, fat, protein, carbohydrates, alcohol, cholesterol, fiber and vitamins A, D or E during the trial (data not shown). However, the intake of polyunsaturated fatty acids decreased in the sterol group but increased in the placebo group during the trial (P ¼ 0.0340 for the difference), and, as expected also the polyunsaturated/ saturated fat intake (P/S ratio) decreased more in the sterol group (P ¼ 0.0320; data not shown). Total intake of plant sterols in the sterol group estimated by 3-day food records was 0.91, 1.86 and 4.17 g per day during the first, second and third 5-week periods, respectively. This was somewhat less than planned in the original study design (1.25, 2.5 and 5.0 g per day).
Discussion
The baseline serum concentrations of sitosterol and campesterol, the main plant sterols in blood, determined in the present study were similar to those reported previously for Finnish patients with mild hypercholesterolemia during their habitual diet (Gylling et al., 1999a) . Despite a significant increase in the mean serum sitosterol concentration of 2.51 mg l À1 (88 %) in the sterol group, the increase in the mean serum total plant sterol concentration at the end of 15 weeks (1.58 mg l
À1
) did not differ significantly from that in the placebo group due to slight compensatory changes in campesterol and avenasterol concentrations. 
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At the end of the trial, the highest individual serum plant sterol levels in the study participants were around 15 mg l
À1
. Hence, the proportion of plant sterols of all sterols (including cholesterol) in serum did not exceed 0.6 % at any point in time. Although the use of food items enriched with nonesterified plant sterols did not significantly affect the total plant sterol concentration in serum at intake levels of up to 5 g per day, the significant elevation of serum sitosterol, although not large in absolute value, merits consideration.
Apart from phytosterolemia (sitosterolemia) (Salen et al., 1992 ), a very rare (homozygoteso1:1000 000, heterozygotes o1:500) autosomal recessive disorder of plant sterol and cholesterol metabolism, there is little evidence of any significant adverse effects of elevated serum plant sterol levels. In people with homozygous phytosterolemia tendon xanthomas and predisposition to atherosclerosis are present (Miettinen, 1980; Lutjohann et al., 1996) . In the few cases of homozygous phytosterolemia, which have been reported, the serum plant sterols levels have been as high as 0.5-1.7 mmol l À1 (approximately 74-255 mg l
) comprising 15% or more of serum total plant sterols (Miettinen, 1980) . Phytosterolemia results from defects in either one of the two ATP-binding cassette (ABC) genes, ABCG5 or ABCG8, which protect against excessive absorption of phytosterols (Patel et al., 1998) . Although the transport proteins produced by these ABC genes mediate the intestinal absorption of all sterols they also effectively return phytosterols back into the intestinal lumen (Patel et al., 1998; Tikkanen, 2005) . Serum plant sterol concentrations are reportedly mildly elevated in part of phytosterolemia heterozygotes, and these are increased by about 30% during phytosterol intake of 2.2 g per day (Kwiterowich et al., 2003) . Common ABC gene polymorphisms participate in the regulation of serum phytosterol concentrations in the general population (Berge et al., 2002) , but subgroups susceptible to excessive phytosterol absorption have not been reported. With the growing market of sterol-enriched foods, some consumers may use a variety of such products, easily resulting in daily sterol intakes of 10 g or more. Previous studies (Jones et al., 1997) have reported that sitosterol intakes ranging from 6 to 12 g per day increased plasma sitosterol levels by 13-68% with compensatory reductions in campesterol in line with our results. However, all reported trials have been short (up to 3 months). On this basis, while there is little evidence that mildly elevated plant sterol levels would be risk factors for cardiovascular disease (Patel and Thompson, 2006) , and the proportion of phytosterols of all sterols did not exceed 0.6% in our short-term trial, possible adverse effects of long-term phytosterol administration cannot be ruled out.
Natural nonesterified plant sterols did not influence plasma b-carotene or retinol levels in this study, but a-tocopherol concentrations were decreased significantly in people receiving foods fortified with plant sterols. In some previous studies esterified plant sterols and plant stanols in margarines have reduced blood carotenoid levels (Weststrate and Meijer, 1998; Gylling et al., 1999b; Hallikainen et al., 1999) . In line with our results, previous studies have documented decreases in a-tocopherol during the intake of plant stanol ester margarine (Gylling et al., 1999b; Gylling and Miettinen, 1999) . The finding that plasma a-tocopherol and other fat-soluble vitamin levels decreased during cholesterol-lowering treatments is explained by the fact that these substances are transported in plasma by lipoprotein particles, LDL being the predominant carrier (Ziouzenkova et al., 1996) . The a-tocopherol/LDL cholesterol ratio remained unchanged in our study as well as in previous studies using plant stanol margarines (Gylling et al., 1999b; Gylling and Miettinen, 1999) confirming that the a-tocopherol content in LDL particles did not change. There were no significant changes in sex hormone levels either in the sterol or placebo groups. In the study of Ayesh et al. (1999) a decrease in progesterone level was observed, but it was not associated with any disturbances in endocrine function. In our study, the progesterone concentrations in menstruating women in the sterol group were higher than in the placebo group. This is probably explained by the fact that the day of sampling was not synchronized with the day of the menstrual cycle. Thus, the differences are likely to be explained by the large variations in serum progesterone concentrations during the menstrual cycle.
Our study shows that a 15-week consumption of natural nonesterified plant sterol-enriched food items did not result in adverse effects of clinical importance. However, serum a-tocopherol levels were somewhat reduced in the sterol group, corresponding to the fall in their carrier protein LDL. Although these alterations are not assumed to cause any adverse effects, it is advisable to explore further long-term effects of plant sterols on serum fat-soluble vitamin concentrations.
